<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1902233259
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PROTENSE 40 mg/5 ml oral solution
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PROPRANOLOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        8
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        110
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jazeera Pharmaceutical Industries (JPI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AA05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Protense Oral Solution contains propranolol hydrochloride. This belongs to a group of medicines called beta-blockers.</p><p>Protense Oral Solution can be used for:</p><ul><li>high blood pressure</li><li>symptoms of chest pain (angina)</li><li>protection against further heart attacks - if you have already had one</li><li>thickened heart muscle &ndash; also called &lsquo;hypertrophic cardiomyopathy&rsquo;</li><li>problems affecting the beat of your heart (arrhythmias, tachycardia).</li></ul><p>It can also be used for:</p><ul><li>severe headaches (migraine)</li><li>shaking (tremors)</li><li>stress (anxiety)</li><li>an overactive thyroid gland &ndash; also called &lsquo;thyrotoxicosis&rsquo;</li><li>bleeding in the food pipe (oesophagus). This happens when the blood pressure is high in your liver</li><li>high blood pressure caused by a tumour on the adrenal gland. This is called &#39;phaeochromocytoma&#39;.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Protense Oral Solution if:</strong></p><ul><li>you are allergic (hypersensitive) to propranolol or any of the other ingredients in this liquid (see section 6: Further information)&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; An allergic reaction can include a rash, itching or shortness of breath</li><li>you have ever had asthma or wheezing</li><li>you have heart problems such as heart failure which is not under control, heart block, slow or uneven heart beats, low blood pressure or very poor circulation</li><li>you have not been eating (fasting) for a long period of time or if your blood has become too acidic (metabolic acidosis)</li><li>you have high blood pressure caused by a tumour on the adrenal gland which has not been treated. This is called &#39;phaeochromocytoma&#39;</li><li>&nbsp;you have or sometimes get low blood sugar (&#39;hypoglycaemia&#39;). This can happen if you are not eating well, have long-term liver disease or have diabetes</li><li>you have chest pain that happens when you are resting rather than during exercise (called &#39;prinzmetals angina&#39;).</li></ul><p>Do not take Protense Oral Solution if any of the above apply to you. If you are not sure, talk to your doctor before taking Protense Oral Solution</p><p><strong>Take special care with Protense Oral Solution</strong></p><p>Before you take Protense Oral Solution tell your doctor if:</p><ul><li>you have heart failure which is being treated</li><li>circulation problems or other heart problems (such as angina or heart attacks)</li><li>you have liver problems (such as cirrhosis) or kidney problems</li><li>&nbsp;you have allergic reactions to things like insect bites</li><li>&nbsp;you have diabetes. This is because Protense may interfere with your body&rsquo;s reaction to low blood sugar</li><li>you have an overactive thyroid gland &ndash; also called &#39;thyrotoxicosis&#39;</li></ul><p><strong>Taking other medicines</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>In particular tell your doctor or pharmacist if you are taking any of the following medicines:</p><ul><li>medicines for diabetes</li><li>medicines used to treat anxiety and depression as well as more serious mental health problems such as chlorpromazine, thioridazine, fluvoxamine, imipramine or MAOIs such as phenelzine and diazepam</li><li>medicines for uneven heart beats such as disopyramide, quinidine, propafenone, lidocaine, flecainide and amiodarone</li><li>medicines for chest pain (angina) or high blood pressure such as verapamil, nifedipine, diltiazem, nisoldipine, nicardipine, isradipine, lacidipine</li><li>medicines used to treat high blood pressure such as hydralazine, captopril (ACE inhibitors), furosemide and other water tablets (diuretics), losartan and candesartan, diazoxide, doxazosin, guanethidine, moxisylyte, moxonidine, nitrates (such as glyceryl trinitrate and isosorbide dinitrate) and methyldopa</li><li>medicines for stimulating the heart such as adrenaline and dobutamine</li><li>medicines for pain and inflammation including arthritis such as ibuprofen or indomethacin</li><li>steroids used to reduce swelling such as prednisolone and dexamethasone</li><li>medicines used to treat myasthenia gravis such as neostigmine</li><li>&nbsp;medicines used to relax muscles such as baclofen and tizanidine</li><li>medicines to help you sleep or to treat epilepsy known as barbiturates such as phenobarbital</li><li>&nbsp;medicines used to treat parkinsons disease such as levodopa</li><li>ergotamine, dihydroergotamine and rizatriptan - used for migraine</li><li>digoxin and warfarin - used for heart failure</li><li>cimetidine - used for too much stomach acid</li><li>rifampicin - used for tuberculosis</li><li>theophylline - used for asthma</li><li>mefloquine - used to prevent malaria</li><li>aldesleukin - used for kidney cancer</li><li>alprostadil - used to help men get or keep an erection or to test for erection problems</li><li>oestrogens - used in hormone replacement therapy (HRT)</li><li>clonidine - used for high blood pressure and migraine. You must not stop taking clonidine unless your doctor tells you to. If you have to stop taking it, your doctor will tell you how to do it.</li></ul><p><strong>Operations and Tests </strong></p><p>Tell your doctor, dentist or nurse you are taking Protense Oral Solution if:</p><ul><li>&nbsp; you are going to have an operation or an anaesthetic. This is because you can get low blood pressure (hypotension) if you are given certain anaesthetics while you are taking Protense Oral Solution</li><li>you are going to have any blood or urine tests.</li></ul><p><strong>Taking Protense Oral Solution with food and drink</strong></p><p>Do not drink alcohol while taking Protense Oral Solution. This is because alcohol can change the way the Protense works.</p><p><strong>Pregnancy and Breast-feeding </strong></p><p>Talk to your doctor before taking this medicine if you are pregnant, planning to become pregnant or are breast-feeding.</p><p><strong>Driving and using machines</strong></p><p>Protense is not likely to affect you being able to drive or use any tools or machines. However, sometimes you may feel dizzy or tired while taking Protense. If this happens, do not drive or use any tools or machines and tell your doctor.</p><p><strong>Important information about what is in Protense Oral Solution </strong></p><p>This medicine contains:</p><ul><li>Sorbitol. If your doctor has told you that you cannot tolerate some sugars, see your doctor before taking this medicine</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Taking this medicine</strong></p><p>Take this medicine as your doctor or pharmacist has told you. Look on the label and ask the doctor or pharmacist if you are not sure.</p><ul><li>This medicine contains 40mg of propranolol in each 5ml</li><li>Take this medicine by mouth</li><li>Do not stop taking this medicine unless your doctor tells you to stop.</li></ul><p><strong>Adults</strong></p><p>The usual doses range from 30mg - 320mg daily depending on what condition you are taking the medicine for.</p><p><strong>Children</strong></p><p>Your doctor will decide on the amount of Protense to give to your child based on their weight.</p><p><strong>Elderly </strong></p><p>Your doctor will decide how much Protense Oral Solution to give you. They may start you on a lower dose.</p><p><strong>If you take more Protense Oral Solution than you should </strong></p><p>Talk to your doctor or go to a hospital straight away.</p><p><strong>If you forget to take Protense Oral Solution </strong></p><p>Do not take a double dose to make up for forgotten doses. Take your next dose as soon as you remember. Then go on as before.</p><p><strong>If you stop taking Protense Oral Solution</strong></p><p>Keep taking this medicine until your doctor tells you to stop. You may have to stop taking this medicine gradually. Your doctor will help you do this.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Protense Oral Solution can cause side effects although not everybody gets them.</p><p><strong>If you get any of the following side effects, see a doctor straight away:</strong></p><ul><li>any kind of skin rash, flaking skin, boils or sore lips and mouth. You could also notice sudden wheezing, fluttering or tightness of the chest or collapse.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;This may mean you are having an allergic reaction to Protense Oral Solution</li><li>if you develop asthma or breathing problems.</li></ul><p><strong>If you get any of the following side effects, stop taking Protense Oral Solution and see your doctor as soon as possible:</strong></p><p><strong>Common (affects less than 1 in 10 people)</strong></p><ul><li>slow heart beats.</li></ul><p><strong>Rare (affects less than 1 in 1000 people)</strong></p><ul><li>heart failure getting worse (signs include being breathless or swollen ankles), feeling dizzy or light-headed when standing quickly</li><li>dizziness and fainting, worsening of breathing (called &lsquo;heart block&rsquo;)</li><li>&nbsp;poor circulation getting worse. This can lead to cramp-like pains in the lower leg</li><li>bruising more easily or purplish marks on the skin.</li></ul><p><strong>Very rare (affects less than 1 in 10,000 people)</strong></p><ul><li>muscle weakness and a disease of the muscles (called &lsquo;myasthenia gravis&rsquo;) getting worse</li><li>low blood sugar (hypoglycaemia) in children or elderly who do not have diabetes (signs include weakness, headache, feeling hungry, visual disturbances and mood changes). Hypoglycaemia may lead to fits (seizures).</li></ul><p><strong>Tell your doctor if you get any of these side effects: </strong></p><p><strong>Common (affects less than 1 in 10 people)</strong></p><ul><li>feeling cold, numbness and spasm in the fingers and toes</li><li>nightmares, tiredness or difficulty sleeping.</li></ul><p><strong>Uncommon (affects less than 1 in 100 people)</strong></p><ul><li>feeling or being sick</li><li>stomach ache</li><li>diarrhoea.</li></ul><p><strong>Rare (affects less than 1 in 1000 people)</strong></p><ul><li>feeling confused or dizzy</li><li>changes in your mood</li><li>memory loss</li><li>mental illness where a person loses touch with reality (psychoses)</li><li>strange sounds and visions (hallucinations)</li><li>thinning of the hair</li><li>skin rash, worsening of skin problem called &lsquo;psoriasis&rsquo;</li><li>dry eyes, changes in your sight</li><li>tingling sensation (pins and needles) particularly in the hands.</li></ul><p>If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><ul><li>Keep out of the reach and sight of children.</li><li>Do not store above 30&deg;C. Do not refrigerate or freeze.</li><li>Take back to the pharmacy 3 months after you first open it.</li><li>Do not use after the expiry date (month, year) stated on the label and carton.</li><li>Do not use Protense Oral Solution if you notice anything wrong with the medicine. Talk to your pharmacist.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient is propranolol hydrochloride. The other ingredients are Citric acid monohydrate; Disodium edetate; Methyl Paraben; Propyl Paraben; Polyethylene glycol 400; Propylene Glycol; Saccharin sodium; Sorbitol; Strawberry flavor; Peppermint flavor; Deionized Water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Protense solution are: clear colorless, strawberry flavored with pleasant odor.
It comes in a 130 ml White HDPE bottle with White child resistant cap with Plug.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><u>Marketing Authorisation Holder:</u></p><p>Jazeera Pharmaceutical Industries (JPI)</p><p>Riyadh, Saudi Arabia, 11666 Riyadh, P.O.Box 106229</p><p>Phone No.: +966-11-207-8172</p><p>Fax: +966-11-207-8097</p><p>E-mail:<u> medical@jpi.com.sa </u></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 01/2016, version 1.2
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="margin-left:0in; margin-right:7.25pt; text-align:right">يحتوي ﺷراب ﺑروتنس&nbsp;ﻋﻠﻰ المادة اﻟﻔﻌﺎﻟﺔ: هيدروﻛلوريد ﺑروﺑراﻧوﻟول . تنتمي هذه اﻟﻣﺎدة إﻟﻰ ﻣﺟﻣوﻋﺔ ﻣن اﻷدوية ﺗﺳﻣﻰ ﺣﺎﺻرات بيتا&nbsp; .</p><p dir="RTL" style="margin-left:0in; margin-right:7.3pt; text-align:right">يمكن اﺳﺗﺧدام ﺷراب ﺑروﺗﻧس ﻟﻣﺎيلي :</p><ul dir="rtl"><li style="text-align:right">&nbsp;ارﺗﻔﺎع ﺿﻐط اﻟدم</li><li style="text-align:right">أﻋراض أﻟم ﻓﻲ اﻟﺻدر ( اﻟذﺑﺣﺔ اﻟﺻدرية )</li><li style="text-align:right">ﺣﻣﺎية ﺿد اﻟﻣزيد ﻣن اﻟﻧوﺑﺎت اﻟﻘﻠﺑية - إذا ﻛﻧت ﻗد اﺻبت ﺑﻧوﺑﺔ ﻗﻠﺑية ﻣن ﻗﺑل.</li><li style="text-align:right">ﺳﻣﺎﻛﺔ ﻋﺿﻠﺔ اﻟﻘﻠب - وﺗﺳﻣﻰ أيضا &quot; اﻋﺗﻼل ﻋﺿﻠﺔ اﻟﻘﻠب اﻟﺿﺧﺎﻣﻲ &quot;</li><li style="text-align:right">اﻟﻣﺷﻛﻼت اﻟﺗﻲ ﺗؤﺛر ﻋﻠﻰ دﻗﺎت قلبك&nbsp;( عدم انتظام&nbsp;ضربات القلب، عدم انتظام&nbsp;دﻗﺎت القلب&nbsp;)</li></ul><p dir="RTL" style="margin-left:0in; margin-right:7.25pt; text-align:right">ﻛﻣﺎ أنه يستخدم&nbsp; لما يلي :</p><ul dir="rtl"><li style="text-align:right">اﻟﺻداع اﻟﺷديد ( اﻟﺻداع اﻟﻧﺻﻔﻲ )</li><li style="text-align:right">اﻟرﺟﻔﺎن ( اﻟهزات )</li><li style="text-align:right">اﻹجهاد ( اﻟﻘﻠق )</li><li style="text-align:right">فرط نشاط الغدة الدرقية - وتسمى أيضا &quot;الانسمام الدرقي&quot;</li><li style="text-align:right">نزيف في المريء. يحدث هذا عندما يكون ضغط الدم مرتفع في الكبد</li><li style="text-align:right">&nbsp;ارتفاع ضغط الدم الناجم عن وجود ورم في الغدة الكظرية. وهذا ما يسمى &quot;ورم القواتم&quot;.</li></ul><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تأخذ بروتنس في الحالات التالية: </strong></p><ul><li dir="rtl">&nbsp;لديك حساسية لبروبرانولول أو أي من المكونات الأخرى في هذا الشراب (انظر القسم 6 :مزيد من المعلومات) رد الفعل التحسسي يمكن أن تشمل الطفح الجلدي والحكة أو ضيق في التنفس</li><li dir="rtl">كان لديك أي وقت مضى الربو أو الصفير</li><li dir="rtl">لديك مشاكل في القلب مثل قصور القلب وهي ليست تحت السيطرة، وانسداد القلب، دقات القلب بطيئة أو غير متساوية، وانخفاض ضغط الدم أو ضعف الشديد فى الدورة الدموية.</li><li dir="rtl">لديك لم تتناول الطعام (الصيام) لفترة طويلة من الزمن أو إذا أصبح دمك حامضي جدا (الحماض الأيضي)</li><li dir="rtl">لديك ارتفاع ضغط الدم الناجم عن وجود ورم في الغدة الكظرية التي لم يتم علاجها. وهذا ما يسمى &quot;ورم القواتم&#39;</li><li dir="rtl">لديك أو في بعض الأحيان قد ينخفض السكر في الدم (&#39;نقص سكر الدم&#39;). هذا يمكن أن يحدث إذا كنت لا تأكل جيدا، لديك مرض الكبد على المدى الطويل أو لديك مرض السكري</li><li dir="rtl">لديك ألم في الصدر يحدث عند الراحة بدلا من أثناء ممارسة الرياضة (يسمى الذبحة الصدرية &quot;برنزميتال&quot;).</li></ul><p>لا تأخذ بروتنس إذا كان أي من أعلاه تنطبق عليك. إذا لم تكن متأكدا، تحدث مع طبيبك قبل استعمال بروتنس.</p><p><strong>التحذيرات والاحتياطات</strong></p><p>قبل استعمال شراب بروتنس<strong> </strong>اخبر طبيبك إذا:</p><ul><li dir="rtl">لديك قصور القلب تجري معالجته.</li><li dir="rtl">مشاكل في الدورة الدموي أو مشاكل أخرى في القلب (مثل الذبحة الصدرية أو النوبات القلبية) &bull;</li><li dir="rtl">لديك مشاكل في الكبد (مثل تليف الكبد) أو مشاكل في الكلى</li><li dir="rtl">لديك حساسية لأشياء مثل الحساسية للدغات الحشرات</li><li dir="rtl">كان لديك مرض السكري. وذلك لأن بروتنس قد تتداخل مع رد فعل الجسم عند انخفاض السكر في الدم</li><li dir="rtl">لديك فرط نشاط الغدة الدرقية - وتسمى أيضا &quot;الانسمام الدرقي&quot;.</li></ul><p><strong>تناول الأدوية الأخرى مع بروتنس</strong></p><p>يرجى إخبار الطبيب أو الصيدلي إذا كنت تأخذ أو استخدمت مؤخرا أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها دون وصفة طبية.</p><p>وعلى وجه الخصوص أخبر طبيبك أو الصيدلي إذا كنت تأخذ أي من الأدوية التالية:</p><ul><li dir="rtl">أدوية السكر</li><li dir="rtl">الأدوية المستخدمة لعلاج القلق والاكتئاب وكذلك مشاكل الصحة العقلية الأكثر خطورة مثل الكلوربرومازين، ثيوريدازين، فلوفوكسامين، إيميبرامين أو اوكسيداز احادي الأمين مثل فينيلزين والديازيبام</li><li dir="rtl">الأدوية لعلاج ضربات القلب الغير متناسقة مثل ديسوبيراميد، كينيدين، بروبافينون، ليدوكائين، فليكاينيد واميودارون</li><li dir="rtl">&nbsp;الأدوية لآلالم الصدر (الذبحة الصدرية) أو ارتفاع ضغط الدم مثل فيراباميل، نيفيديبين، ديلتيازيم، نيسولديبين، نيكارديبين، عقار الإسراديبين، لاسيديبين</li><li dir="rtl">الأدوية المستخدمة لعلاج ارتفاع ضغط الدم مثل الهيدرالازين، كابتوبريل (مثبطات الإنزيم المحول للأنجيوتنسين)، فوروسيميد وأقراص المائية الأخرى (مدرات البول)، اللوسارتان وكانديسارتان، ديازوكسيد، دوكسازوسين، غوانيثيدين، تيرازوسين، موكسينيدين، والنترات (مثل ثلاثى غليسيريل و ثنائي نترات الإيزوسوربيد) وميثيل دوبا.</li><li dir="rtl">الأدوية لتنشيط القلب مثل الأدرينالين والدوبوتامين</li><li dir="rtl">&nbsp;الأدوية للألم والالتهاب بما في ذلك التهاب المفاصل مثل ايبوبروفين أو اندوميثاسين</li><li dir="rtl">استخدام الستيرويدات للحد من التورم مثل بريدنيزولون وديكساميثازون</li><li dir="rtl">الأدوية المستخدمة لعلاج الوهن العضلي الوبيل مثل النيوستيغمين</li><li dir="rtl">الأدوية المستخدمة لاسترخاء العضلات مثل باكلوفين وتيزانيدين</li><li dir="rtl">الأدوية لمساعدتك على النوم أو لعلاج الصرع المعروفة باسم الباربيتورات مثل الفينوباربيتال</li><li dir="rtl">&nbsp;الأدوية المستخدمة في علاج مرض باركنسون مثل ليفودوبا</li><li dir="rtl">الإرغوتامين، ثنائي هيدروأرغوتامين وريزاتربتان - تستخدم لعلاج الصداع النصفي</li><li dir="rtl">الديجوكسين والوارفارين - تستخدم لقصور القلب</li><li dir="rtl">سيميتيدين - تستخدم لالكثير من حمض المعدة</li><li dir="rtl">&nbsp;ريفامبيسين - تستخدم لمرض السل</li><li dir="rtl">&nbsp;الثيوفيلين - تستخدم لعلاج الربو</li><li dir="rtl">&nbsp;الميفلوكين - تستخدم للوقاية من الملاريا&nbsp;</li><li dir="rtl">ألدسلوكين -تستخدم لسرطان الكلى</li><li dir="rtl">&nbsp;آلبروستاديل - يستخدم لمساعدة الرجال على الحصول أو الحفاظ على الانتصاب أو لاختبار لمشاكل الانتصاب</li><li dir="rtl">الاستروجين - المستخدمة في العلاج بالهرمونات البديلة (HRT)</li><li dir="rtl">الكلونيدين - تستخدم لارتفاع ضغط الدم والصداع النصفي. يجب أن لا تتوقف عن تناول الكلونيدين&nbsp;ما لم يخبرك طبيبك بذلك. إذا كان عليك التوقف عن تناوله، طبيبك سوف يخبرك بكيفية القيام بذلك.</li></ul><p><strong>العمليات والفحوصات</strong></p><p>أخبر طبيبك أو طبيب الأسنان أو الممرضة اذا كنت تأخذ بروتنس الحل عن طريق الفم في الحالات التالية:</p><ul><li dir="rtl">أنت ذاهب لعملية جراحية أو تخدير. هذا هو لأنه يمكن انخفاض ضغط الدم إذا تم إعطاءك بعض أدوية التخدير وأنت تأخذ بروتنس</li><li dir="rtl">في طريقك لعمل فحوصات للدم أو للبول.</li></ul><p><strong>تناول شراب بروتنس مع الطعام والشراب</strong></p><p>لا تشرب الكحول في حين تناولك لبروتنس. وذلك لأن الكحول يمكن أن تغير الطريقة التي يعمل بها بروتنس.</p><p><strong>الحمل والرضاعة الطبيعية</strong></p><p>تحدثي إلى طبيبك قبل تناول هذا الدواء إذا كنتي حاملا، او تخططين لتصبحي حاملا أو ترضعين رضاعة طبيعية.</p><p><strong>القيادة واستخدام الآلات</strong></p><p>بروتنس ليس من المرجح أن تؤثر على قدرتك على دفع أو استخدام أي أدوات أو آلات. ومع ذلك، في بعض الأحيان قد تشعر بالدوار أو التعب في حين تناول بروتنس .إذا حدث هذا، لا تشغل أو تستخدم أي أدوات أو آلات واخبر الطبيب بذلك.</p><p><strong>معلومات هامة عن بعض مكونات شراب بروتنس</strong></p><p>هذا الدواء يحتوي على:</p><ul><li>السوربيتول. إذا كان طبيبك قد قال لك أنه لايمكنك تحمل بعض السكريات، راجع طبيبك قبل تناول هذا الدواء.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول هذا الدواء</p><p>خذ هذا الدواء كما وصفه لك طبيبك أو الصيدلي . انظر لتعليمات الاستخدام الملصقة على عبوة الدواء من الصيدلية، واستفسر من الطبيب أو الصيدلي إذا لم تكن متأكدا من اي معلومة.&nbsp;</p><ul><li dir="rtl">يحتوي هذا الدواء 40 ملغ من بروبرانولول في كل 5 مل من الشراب</li><li dir="rtl">خذ هذا الدواء عن طريق الفم</li><li dir="rtl">لا تتوقف عن تناول هذا الدواء إلا إذا طلب منك الطبيب أن تتوقف.</li></ul><p><strong>الكبار</strong></p><p>وتتراوح الجرعات المعتادة من 30 ملغ الى 320 ملغ يوميا اعتمادا على حالتك التي توجبت استخدامك للدواء.</p><p><strong>الأطفال</strong></p><p>طبيبك سوف يقرر كمية من بروتنس لإعطاء طفلك على أساس وزنه.</p><p><strong>كبار السن </strong></p><p>طبيبك سوف يقرر كمية شراب بروتنس. ويمكن أن تبدأ جرعتك بجرعة أقل.</p><p><strong>الجرعة الزائدة من تناول بروتنس</strong></p><p>تحدث إلى طبيبك أو اذهب إلى المستشفى على الفور.</p><p><strong>نسيان تناول جرعة بروتنس</strong></p><p>لا تأخذ جرعة مضاعفة لتعويض الجرعات المنسية. خذ الجرعة التالية في أقرب وقت تتذكر. ثم ارجع لترتيبك السابق.</p><p><strong>التوقف عن تناول شراب بروتنس</strong></p><p>حافظ على تناول هذا الدواء حتى يطلب منك طبيبك التوقف. قد تضطر إلى التوقف عن تناول هذا الدواء تدريجيا. طبيبك&nbsp;سوف يساعدك على القيام بذلك. إذا كان لديك أي أسئلة أخرى عن استخدام&nbsp; هذا الدواء، اسأل طبيبك او الصيدلي .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن بروتنس ان يسبب في آثار جانبية على الرغم من أن الجميع لا يحصل لهم.</p><p><strong>اذا كان لديك أي من الآثار الجانبية التالية، يجب مراجعة الطبيب على الفور:</strong></p><ul><li dir="rtl">أي نوع من الطفح الجلدي، وقشور الجلد، والدمامل أو التهاب الشفتين والفم. يمكنك أن تلاحظ أيضا الصفير المفاجئ، ترفرف أو ضيق في الصدر أو الانهيار. وهذا قد يعني انك تواجه رد فعل تحسسي لبروتنس</li><li dir="rtl">إذا كنت تطورت لديك حالة الربو أو مشاكل في التنفس.</li></ul><p><strong>اذا حصلت لديك أي من الآثار الجانبية التالية، توقف عن استخدام شراب بروتنس ومراجعة الطبيب في أقرب وقت ممكن:</strong></p><p><u>شائعة (تؤثر على اقل من مستخدم واحد من 10 مستخدمين):</u></p><ul><li dir="rtl">تباطؤ ضربات القلب</li></ul><p><u>نادرة (تؤثر على اقل من مستخدم واحد من 1000 مستخدم)</u></p><ul><li dir="rtl">فشل القلب يزداد سوءا (تشمل علامات اللهثان أو تورم الكاحلين)، والشعور بالدوار او بالدوخة عند الوقوف بسرعة&nbsp;</li><li dir="rtl">الدوخة والاغماء، وتفاقم التنفس (وتسمى &quot;انسداد القلب&quot;)</li><li dir="rtl">ازدياد ضعف الدورة الدموية سوءا. هذا يمكن أن يؤدي إلى آلام تشبه الاصابة بتمزق عضلي في الجزء الأسفل من الساق</li><li dir="rtl">حصول كدمات بسهولة أكبر أو علامات أرجوانية على الجلد.</li></ul><p><u>نادرة جدا (تؤثر على اقل من مستخدم واحد من كل 10000 مستخدم)</u></p><ul><li dir="rtl">تزايد سوء حالة ضعف العضلات ومرض العضلات (وتسمى &quot;الوهن العضلي الوبيل &#39;)</li><li dir="rtl">انخفاض نسبة السكر في الدم لدى الأطفال أو كبار السن الذين ليس لديهم مرض السكري (تشمل العلامات: الضعف، والصداع، والشعور بالجوع، اضطرابات بصرية وتغيرات في المزاج). نقص سكر الدم يمكن أن يؤدي إلى نوبات التشنجات.</li></ul><p><strong>أخبر طبيبك إذا كان لديك أي من هذه الآثار الجانبية التالية:</strong></p><p><u>شائعة (تؤثر على اقل من مستخدم واحد من 10 مستخدمين)</u>:</p><ul><li dir="rtl">&nbsp;الشعور بالبرد، وخدر وتشنج في أصابع اليدين والقدمين</li><li dir="rtl">الكوابيس، التعب أو صعوبة النوم.</li></ul><p><u>غير شائعة (تؤثر على اقل من مستخدم واحد من 10 مستخدمين):</u></p><ul><li dir="rtl">الشعور أو أن يكون مريضا</li><li dir="rtl">ألم في المعدة</li><li dir="rtl">الإسهال.</li></ul><p><u>نادرة (تؤثر على اقل من مستخدم واحد من 1000 مستخدم)</u></p><ul><li dir="rtl">الشعور بالتيهان او الخلط</li><li dir="rtl">تغيرات في المزاج الخاص بك</li><li dir="rtl">فقدان الذاكرة</li><li dir="rtl">المرض العقلي حيث يفقد الشخص اتصاله بالواقع (الذهان)</li><li dir="rtl">اصوات غريبة و رؤى (الهلوسة)</li><li dir="rtl">ترقق الشعر</li><li dir="rtl">الطفح الجلدي، وتفاقم مشكلة الجلد يسمى &quot;الصدفية&quot;</li><li dir="rtl">&nbsp;جفاف العين، والتغيرات في عينيك</li><li dir="rtl">احساس بالوخز (الإبر والدبابيس) وخاصة في اليدين.</li></ul><p>إذا اصبحت أي من الآثار الجانبية السابقة اكثر خطورة، أو إذا لاحظت أي آثار جانبية غير المذكورة في هذه النشرة، يرجى إخبار الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li>يحفظ بعيدا عن متناول وبصر الأطفال .</li><li>لا يخزن الشراب فوق 30 درجة مئوية. ولا يحفظ في الثلاجة او الفريزر.</li><li>مدة صلاحية الشراب بعد الفتح لاتتجاوز ثلاثة اشهر.</li><li>لا تستخدم الدواء بعد تاريخ انتهاء الصلاحية (الشهر والسنة) كما هو موضح على كرتونة الدواء.</li><li>لا تستخدم شراب بروتنس إذا لاحظت أي شيء خاطئ مع هذا الدواء وتحدث إلى الصيدلي</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp; العنصر النشط هو هيدروكلوريد بروبرانولول.</p><p>المكونات الأخرى هي مونوهيدرات حامض الستريك. الصوديوم إيديتات. الميثيل البارابين. بروبيل بارابين، البولي ايثيلين جلايكول 400 .البروبيلين غليكول. السكرين الصوديوم. السوربيتول. نكهة الفراولة. نكهة النعناع. المياه منزوعة الأيونات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>هو شراب بروتنس هو محلول شفاف اللون بنكهة الفراولة ورائحة لطيفة. يأتي الشراب في زجاجة بيضاء بسعة 130 مل من الشراب مع غطاء مقاوم الفتح لتجنب عبث الأطفال بالعبوة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الجزيرة للصناعات الدوائية (JPI)</p><p>الرياض، المملكة العربية السعودية،</p><p>الرياض 11666 ،صندوق البريد 106229</p><p>الهاتف رقم: 8172-207-11-966+</p><p>فاكس: 8097 -207-11-966+</p><p>البريد الإلكتروني: <u>medical@jpi.com.sa</u></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على هذه النشرة الأخيرة في 01/2016 ،رقم النسخة 2.1



        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Protense 40mg/5ml Oral Solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active ingredient is: Propranolol Hydrochloride 40mg/5ml
Other qualitatives and quantitative per milliliter: Citric acid monohydrate: 0.6 mg/ml; Disodium edetate: 0.2 mg/ml; Methyl Paraben: 2.2 mg/ml;Propyl Paraben: 0.2 mg/ml; Polyethylene glycol 400: 100 mg/ml; Propylene Glycol: 140 mg/ml; Saccharin sodium: 5 mg/ml; Sorbitol: 850 mg/ml; Strawberry flavor:
 6 mg/ml; Peppermint flavor: 1 mg/ml
For the full list of excipients, see Section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral Solution
Clear colorless, strawberry flavored with pleasant odur.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Propranolol is indicated in:</p><ul><li>&nbsp;the control of hypertension</li><li>the management of angina pectoris</li><li>the long term prophylaxis against reinfarction after recovery from acute myocardial infarction</li><li>the control of most forms of cardiac arrhythmia</li><li>the prophylaxis of migraine</li><li>the management of essential tremor</li><li>relief of situational anxiety and generalised anxiety symptoms, particularly those of the somatic type</li><li>prophylaxis of upper gastro-intestinal bleeding in patients with portal hypertension and oesophageal varices</li><li>the adjunctive management of thyrotoxicosis and thyrotoxic crisis</li><li>management of hypertrophic obstructive cardiomyopathy</li><li>management of phaeochromocytoma perioperatively (with an alpha-adrenoceptor blocking drug).</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology </u></p><p>For oral administration only.</p><p><strong>Adults: </strong></p><p><em>Hypertension </em>&ndash; A starting dose of 80mg twice a day may be increased at weekly intervals according to response. The usual dose range is 160&ndash;320mg per day. With concurrent diuretic or other antihypertensive drugs a further reduction of blood pressure is obtained.</p><p><em>Angina, migraine and essential tremor</em> &ndash; A starting dose of 40mg two or three times daily may be increased by the same amount at weekly intervals according to patient response. An adequate response in migraine and essential tremor is usually seen in the range 80&ndash;160mg/day and in angina in the range 120&ndash;240mg/day.</p><p><em>Situational and generalised anxiety</em> &ndash; A dose of 40mg daily may provide short term relief of acute situational anxiety. Generalised anxiety, requiring longer term therapy, usually responds adequately to 40mg twice daily which, in individual cases, may be increased to 40mg three times daily. Treatment should be continued according to response. Patients should be reviewed after six to twelve months treatment.</p><p><em>Arrhythmias, anxiety, tachycardia, hypertrophic obstructive cardiomyopathy and thyrotoxicosis </em>&ndash; A dosage range of 10&ndash;40mg three or four times a day usually achieves the required response.</p><p><em>Post myocardial infarction </em>- Treatment should start between days 5 and 21 after myocardial infarction with an initial dose of 40mg four times a day for 2 or 3 days. In order to improve compliance the total daily dosage may thereafter be given as 80mg twice daily.</p><p><em>Portal hypertension</em>:</p><p>Dosage should be titrated to achieve approximately 25% reduction in resting heart rate. Dosage should begin with 40mg twice daily, increasing to 80mg twice daily depending on heart rate response. If necessary, the dose may be increased incrementally to a maximum of 160mg twice daily.</p><p><em>Phaeochromocytoma</em> (Used only with an alpha-receptor blocking drug) - Preoperative: 60mg daily for three days is recommended.</p><p>Non-operable malignant cases: 30mg daily.</p><p><strong>Children</strong></p><p><em>Arrhythmias, phaeochromocytoma, thyrotoxicosis</em> &ndash; Dosage should be individually determined and the following is only a guide: 250 &ndash; 500 micrograms per kilogram three or four times daily as required.</p><p><em>Migraine </em>&ndash; Under the age of 12: 20mg two or three times daily</p><p>Over the age of 12: the adult dose</p><p><em>Fallots&#39; tetralogy</em> &ndash; The value of propranolol in this condition is confined mainly to the relief of right-ventricular outflow tract shut-down. It is also useful for treatment of associated arrhythmias and angina. Dosage should be individually determined and the following is only a guide: Up to 1mg/Kg repeated three or four times a day as required.</p><p><strong>Elderly</strong></p><p>With regard to the elderly the optimum dose should be individually determined according to the clinical response.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Propranolol must not be used if there is a history of bronchial asthma or bronchospasm.
The product label states the following warning: “Do not take propranolol if you have a history of asthma or wheezing”. A similar warning appears in the patient information leaflet.
Bronchospasm can usually be reversed by beta2-agonist bronchodilators such as salbutamol. 
Large doses of the beta2-agonist bronchodilator may be required to overcome the beta-blockade produced by propranolol and the dose should be titrated according to the clinical response; both intravenous and inhalational administration should be considered. The use of intravenous aminophylline and/or the use of ipratropium (given by nebuliser) may also be considered. Glucagon (1 to 2mg given intravenously) has also been reported to produce a bronchodilator effect in asthmatic patients. Oxygen or artificial ventilation may be required in severe cases.
Propranolol as with other beta-adrenoceptor blocking drugs must not be used in patients with any of the following:
Hypersensitivity to propranolol hydrochloride or any of the ingredients; the presence of second or third degree heart block; in cardiogenic shock; metabolic acidosis; after prolonged fasting; bradycardia; hypotension; severe peripheral arterial circulatory disturbances; sick sinus syndrome; untreated phaeochromocytoma; uncontrolled heart failure or Prinzmetal's angina.

Propranolol must not be used in patients prone to hypoglycaemia, i.e. patients after prolonged fasting or patients with restricted counter-regulatory reserves. Patients with restricted counter-regulatory reserves may have reduced autonomic and hormonal responses to hypoglycaemia which includes glycogenolysis, gluconeogenesis and/or impaired modulation of insulin secretion. Patients at risk for an inadequate response to hypoglycaemia includes individuals with malnutrition, prolonged fasting, starvation, chronic liver disease, diabetes and concomitant use of drugs which block the full response to catecholamines.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Although contra-indicated in uncontrolled heart failure, propranolol may be used where the signs of heart failure have been controlled by the use of appropriate concomitant medication.Propranolol should be used with caution in patients whose cardiac reserve is poor.</p><p>Treatment should not be discontinued abruptly in patients with ischaemic heart disease. Either the equivalent dose of another beta-adrenoceptor blocking drug may be substituted or the withdrawal of propranolol should be gradual.</p><p>Propranolol should not be used in combination with calcium channel blockers with negative inotropic effects (e.g. verapamil, diltiazem), as it can lead to an exaggeration of these effects particularly in patients with impaired ventricular function and/or SA or AV conduction abnormalities.This may result in severe hypotension, bradycardia and cardiac failure. Neither the beta-blocker nor the calcium channel blocker should be administered intravenously within 48 hours of discontinuing the other.</p><p>Propranolol may block/modify the signs and symptoms of hypoglycaemia (especially tachycardia). Propranolol occasionally causes hypoglycaemia, even in non-diabetic patients, e.g. neonates, infants, children, elderly patients, patients on haemodialysis or patients suffering from chronic liver disease and patients suffering from overdose. Severe hypoglycaemia associated with propranolol has rarely presented with seizures and/or coma in isolated patients. Caution must be exercised in the concurrent use of propranolol and hypoglycaemic therapy in diabetic patients. Propranolol may prolong the hypoglycaemic response to insulin (see section 4.3).</p><p>When a patient is scheduled for surgery and a decision is made to discontinue betablocker therapy, this should be done at least 24 hours prior to the procedure. The risk/benefit of stopping beta blockade should be made for each patient.</p><p>Propranolol should not be used in untreated phaeochromocytoma. However, in patients with phaeochromocytoma, an alpha-blocker may be given concomitantly.</p><p>Although contra-indicated in severe peripheral arterial circulatory disturbances, propranolol may also aggravate less severe peripheral arterial circulatory disturbances. One of the pharmacological actions of propranolol is to reduce the heart rate.</p><p>Therefore the dosage should be reduced in those rare cases where symptoms are attributable to a slow heart rate.</p><p>Due to propranolol having a negative effect on conduction time, caution must be exercised if it is given to patients with first degree heart block.</p><p>Since the half life may be increased in patients with significant hepatic or renal impairment, caution must be exercised when starting treatment and selecting the initial dose.</p><p>In patients with portal hypertension, liver function may deteriorate and hepatic encephalopathy may develop. There have been reports suggesting that treatment with propranolol may increase the risk of developing hepatic encephalopathy.</p><p>Propranolol may cause a more severe reaction to a variety of allergens, when given to patients with a history of anaphylactic reaction to such allergens. Such patients may be unresponsive to the usual doses of adrenaline used to treat the allergic reactions.</p><p>Propranolol may mask the signs of thyrotoxicosis.</p><p>Propranolol must be used with caution in patients with decompensated cirrhosis.</p><p>Propranolol should be used to treat the elderly with caution starting with a lower dose (see section 4.2)</p><p>Laboratory Tests: Propranolol has been reported to interfere with the estimation of serum bilirubin by the diazo method and with the determination of catecholamines by methods using fluorescence.</p><p><em>Excipient Warnings </em></p><p>This product contains parahydroxybenzoates which may cause allergic reactions (possibly delayed).</p><p>This product also contains liquid maltitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.</p><p>In addition, this product contains Sunset Yellow (E110) which may cause allergic reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Hypoglycaemic agents:</em> Tachycardia associated with hypoglycaemia may be modified by propranolol. Use of propranolol alongside hypoglycaemic therapy in diabetic patients should be with caution since it may prolong the hypoglycaemic response to insulin.</p><p><em>Clonidine: </em>Caution should be exercised when transferring patients from clonidine to betaadrenoceptor blocking drugs. If propranolol and clonidine are given concurrently, clonidine should not be discontinued until several days after the withdrawal of the beta blocker. If replacing clonidine by beta-adrenoceptor blocking drug therapy, the introduction of the betaadrenoceptor blocking drugs should be delayed for several days after clonidine administration has stopped.</p><p><em>Anti-arrhythmics: </em>Class I anti-arrhythmic drugs (e.g. disopyramide and flecainide) may have a potentiating effect on atrial-conduction time and induce negative inotropic effect. Concomitant use with class III anti-arrhythmic drugs (e.g. amiodarone) increases the risk of bradycardia, AV block and myocardial depression.</p><p><em>Calcium Channel Blockers: </em>Combined use of beta-adrenoceptor blocking drugs and calcium channel blockers with negative inotropic effects (eg, verapamil, diltiazem) can lead to an exaggeration of these effects particularly in patients with impaired ventricular function and/or SA or AV conduction abnormalities. This may result in severe hypotension, bradycardia and cardiac failure. Neither drug should be administered intravenously within 48 hours of discontinuing the other.</p><p><em>Dihydropyridines:</em> Concomitant therapy with dihydropyridines e.g. nifedipine, may increase the risk of hypotension, and cardiac failure may occur in patients with latent cardiac insufficiency.</p><p><em>Digitalis Glycosides: </em>These preparations in association with beta-adrenoceptor blocking drugs may increase atrio-ventricular conduction time.</p><p><em>Drugs with hypotensive effects: </em>Dynamic interactions between propranolol and other drugs with hypotensive effects are to be expected. Reactions are sometimes severe and careful monitoring is advised in co-administration of propranolol with other drugs including ACE inhibitors, diuretics, angiotensin II receptor antagonists, vasodilator antihypertensives, diazoxide, adrenergic neurone blockers, alpha blockers, moxisylyte, moxonidine, nitrates and methyldopa.</p><p><em>Anaesthesia:</em> Caution must be exercised when using anaesthetic agents with propranolol. The anaesthetist should be informed and the choice of anaesthetic should be the agent with as little negative inotropic activity as possible. Use of beta-adrenoceptor blocking drugs with anaesthetic drugs may result in attenuation of the reflex tachycardia and increase the risk of hypotension. Anaesthetic agents causing myocardial depression are best avoided.</p><p><em>Lidocaine / Bupivacaine: </em>Administration of propranolol during infusion of lidocaine may increase the plasma concentration of lidocaine by approximately 30%. Patients already receiving propranolol tend to have higher lidocaine levels than controls. The combination should be avoided. There is an increased risk of bupivacaine toxicity when used with propranolol.</p><p><em>Neostigmine and other anticholinesterases: </em>Propranolol reduces the efficacy of these compounds in treatment of myasthenia gravis.</p><p><em>Sympathomimetic Agents and Parenteral Adrenaline: </em>Concomitant use of sympathomimetic agents e.g. adrenaline and dobutamine, may counteract the effect of beta-adrenoceptor blocking drugs. Caution should be taken in the parenteral administration of preparations containing adrenaline to people taking beta-adrenoceptor blocking drugs as, in rare cases, vasoconstriction, hypertension and bradycardia may result.</p><p><em>Muscle relaxants (e.g. baclofen): </em>Concomitant use may result in a fall in blood pressure. Tizanidine may also result in bradycardia.</p><p><em>Antidepressants, anxiolytics and hypnotics: </em>Plasma levels of propranolol can be increased by fluvoxamine. Anxiolytics, hypnotics and MAOIs when given with propranolol may have an enhanced hypotensive effect. Propranolol may increase plasma concentration of imipramine. Barbiturates may reduce the plasma concentration of propranolol.</p><p><em>Chlorpromazine: </em>Concomitant administration with propranolol may result in an increase in plasma levels of both drugs. This may lead to an enhanced antipsychotic effect for chlorpromazine and an increased antihypertensive effect for propranolol.</p><p><em>Corticosteroids: </em>Can antagonise the effects of beta-blockers.</p><p><em>Ergotamine: </em>Caution should be exercised if ergotamine, dihydroergotamine or related compounds are given in combination with propranolol since vasospastic reactions have been reported in a few patients.</p><p><em>Prostaglandin Synthetase Inhibiting Drugs: </em>Concomitant use of these e.g. ibuprofen or indomethacin, may decrease the hypotensive effects of propranolol.</p><p><em>Mefloquine: </em>May lead to an increased risk of bradycardia.</p><p><em>Cimetidine, hydralazine: </em>Concomitant use of cimetidine and hydralazine will increase the plasma level of propranolol.</p><p><em>Alcohol (ethanol): </em>Coadministration with alcohol may increase plasma propranolol levels (by enzyme inhibition), where as chronic use of alcohol may lower propranolol levels (by enzyme induction). Alcohol can have variable effects on the hypotensive action of propranolol.</p><p><em>Dopaminergics (e.g. Levodopa), Aldesleukin, Prostaglandins (alprostadil): </em>May have an enhanced hypotensive effect when used concomitantly with propranolol.</p><p><em>Oestrogens: </em>May antagonise the hypotensive effect of propranolol.</p><p><em>5HT<sub>1</sub> agonists: </em>Propranolol may increase plasma concentrations of rizatriptan.</p><p>Pharmacokinetic studies have shown that the following agents may interact with propranolol due to effects on enzyme systems in the liver which metabolise propranolol and these agents: quinidine, propafenone, rifampicin, theophylline, warfarin, thioridazine and dihydropyridine calcium channel blockers such as nifedipine, nisoldipine, nicardipine, isradipine and lacidipine. Owing to the fact that blood concentrations of either agent may be affected, dosage adjustments may be needed according to clinical judgement. (See also the interaction above concerning the concomitant therapy with dihydropyridine calcium channel blockers).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy category C</p><p>As with all drugs, propranolol should not be given in pregnancy unless absolutely essential. There is no evidence of teratogenicity with propranolol. However, beta adrenoceptor blocking agents reduce placenta perfusion, which may result in intrauterine foetal death, immature and premature deliveries. In addition, adverse effects (especially hypoglycaemia and bradycardia in the neonate and bradycardia in the foetus) may occur. There is an increased risk of cardiac and pulmonary complications in the neonate in the post-natal period.</p><p>Most beta-adrenoceptor blocking drugs particularly lipophilic compounds, will pass into breast milk although to a variable extent. Breast feeding is therefore not recommended following administration of these compounds.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use is unlikely to result in any impairment of the ability of patients to drive or operate machinery. However, it should be taken into account that occasionally dizziness or fatigue may occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Propranolol is usually well tolerated, however, listed below are the side effects that may occur:</p><table cellspacing="0" cellpadding="0" border="1" style="width:0px"><tbody><tr><td style="height:52pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">System</p></td><td style="height:52pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">Common</p><p style="margin-left:1.8pt; margin-right:0in">&ge;1/100 to &lt;1/10</p></td><td style="height:52.0pt; vertical-align:top; width:112.7pt"><p style="margin-left:1.8pt; margin-right:0in">Uncommon</p><p style="margin-left:1.8pt; margin-right:0in">&ge;1/1,000 to &lt;1/100</p></td><td style="height:52.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Rare</p><p style="margin-left:1.9pt; margin-right:0in">&ge;1/10,000 to &lt;1/1,000)</p></td><td style="height:52.0pt; vertical-align:top; width:67.35pt"><p style="margin-left:1.8pt; margin-right:0in">Very Rare</p><p style="margin-left:1.8pt; margin-right:0in">&lt;1/10,000</p></td></tr><tr><td style="height:42pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Blood and lymphatic</p><p style="margin-left:1.9pt; margin-right:0in">system disorders:</p></td><td style="height:42pt; vertical-align:top; width:48px"><p>&nbsp;</p></td><td style="height:42.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:42.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Thrombocytopenia</p></td><td style="height:42.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:41pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Metabolism and nutrition</p><p style="margin-left:1.9pt; margin-right:0in">disorders:</p></td><td style="height:41pt; vertical-align:top; width:48px"><p>&nbsp;</p></td><td style="height:41.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:41.0pt; vertical-align:top; width:112.8pt"><p>&nbsp;</p></td><td style="height:41.0pt; vertical-align:top; width:67.35pt"><p style="margin-left:1.8pt; margin-right:0in">Hypoglycaemia</p></td></tr><tr><td style="height:42pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Psychiatric disorders :</p></td><td style="height:42pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">Sleep disturbances,</p><p style="margin-left:1.8pt; margin-right:0in">Nightmares, Insomnia</p></td><td style="height:42.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:42.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Confusion, Mood changes,</p><p style="margin-left:1.9pt; margin-right:0in">Psychoses, Hallucinations</p></td><td style="height:42.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:182pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Nervous system disorders:</p></td><td style="height:182pt; vertical-align:top; width:48px"><p>&nbsp;</p></td><td style="height:182.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:182.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Dizziness, Memory loss,</p><p style="margin-left:1.9pt; margin-right:0in">Paraesthesia especially of</p><p style="margin-left:1.9pt; margin-right:0in">the hands</p></td><td style="height:182.0pt; vertical-align:top; width:67.35pt"><p style="margin-left:1.8pt; margin-right:0in">Seizures have</p><p style="margin-left:1.8pt; margin-right:0in">been linked to</p><p style="margin-left:1.8pt; margin-right:0in">hypoglycaemia</p><p style="margin-left:1.8pt; margin-right:0in">[Hypoglycaemic</p><p style="margin-left:1.8pt; margin-right:0in">seizure],</p><p style="margin-left:1.8pt; margin-right:0in">Isolated reports</p><p style="margin-left:1.8pt; margin-right:0in">of myasthenia</p><p style="margin-left:1.8pt; margin-right:0in">gravis have</p><p style="margin-left:1.8pt; margin-right:0in">been reported</p><p style="margin-left:1.8pt; margin-right:0in">in patients</p><p style="margin-left:1.8pt; margin-right:0in">administered</p><p style="margin-left:1.8pt; margin-right:0in">propranolol</p></td></tr><tr><td style="height:42pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Eye disorders:</p></td><td style="height:42pt; vertical-align:top; width:48px"><p>&nbsp;</p></td><td style="height:42.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:42.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Dry eyes, Visual</p><p style="margin-left:1.9pt; margin-right:0in">disturbances</p></td><td style="height:42.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Cardiac disorders:</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">Bradycardia</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Heart failure</p><p style="margin-left:1.9pt; margin-right:0in">deterioration, Heart block,</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">&nbsp;</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Congestive cardiac failure</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Vascular disorders:</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">Cold extremities,</p><p style="margin-left:1.8pt; margin-right:0in">Raynaud&#39;s phenomenon</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Exacerbation of</p><p style="margin-left:1.9pt; margin-right:0in">claudication, Postural</p><p style="margin-left:1.9pt; margin-right:0in">hypotension which may be</p><p style="margin-left:1.9pt; margin-right:0in">associated with syncope</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Respiratory, thoracic and</p><p style="margin-left:1.9pt; margin-right:0in">mediastinal disorders:</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Bronchospasm (especially</p><p style="margin-left:1.9pt; margin-right:0in">in patients with a history</p><p style="margin-left:1.9pt; margin-right:0in">of asthma) sometimes</p><p style="margin-left:1.9pt; margin-right:0in">with a fatal outcome (see</p><p style="margin-left:1.9pt; margin-right:0in">Section 4.3)</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Gastrointestinal disorders:</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>Gastrointestinal</p><p>disturbance, Nausea,</p><p>Vomiting, Diarrhoea</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Skin and subcutaneous</p><p style="margin-left:1.9pt; margin-right:0in">tissue disorders:</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">Purpura, Alopecia,</p><p style="margin-left:1.9pt; margin-right:0in">Psoriasiform skin</p><p style="margin-left:1.9pt; margin-right:0in">reactions, Exacerbation of</p><p style="margin-left:1.9pt; margin-right:0in">psoriasis, Skin rashes</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Musculoskeletal and</p><p style="margin-left:1.9pt; margin-right:0in">connective tissue</p><p style="margin-left:1.9pt; margin-right:0in">disorders:</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">Muscle fatigue</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">General disorders and</p><p style="margin-left:1.9pt; margin-right:0in">administration site</p><p style="margin-left:1.9pt; margin-right:0in">conditions:</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">Lassitude</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>&nbsp;</p></td></tr><tr><td style="height:32pt; vertical-align:top; width:122px"><p style="margin-left:1.9pt; margin-right:0in">Investigations:</p></td><td style="height:32pt; vertical-align:top; width:48px"><p style="margin-left:1.8pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.7pt"><p>&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:112.8pt"><p style="margin-left:1.9pt; margin-right:0in">&nbsp;</p></td><td style="height:32.0pt; vertical-align:top; width:67.35pt"><p>An increase in</p><p>ANA</p><p>(antinuclear</p><p>antibodies)</p><p>although the</p><p>clinical</p><p>relevance of</p><p>this has not</p><p>been</p><p>established.</p></td></tr></tbody></table><p>If these effects occur, thought should be given to withdrawing the drug. However, it should be withdrawn gradually.</p><p>Bradycardia and hypotension are usually a sign of overdosage but may be rarely linked to intolerance. If this occurs the drug should be withdrawn and overdosage treatment initiated.</p><p><u>Reporting of suspected adverse reactions </u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.</p><p>Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system applied at their country.</p><ul><li><strong>Saudi Arabia:&nbsp;</strong></li></ul><p>_ The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>Fax: +966-11-205-7662</p><p>Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>Toll free phone: 8002490000</p><p>E-mail: <u>npc.drug@sfda.gov.sa </u></p><p>Website: <u>www.sfda.gov.sa/npc</u></p><ul><li><strong>Other GCC States:</strong> Please contact the relevant competent authority.</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The symptoms of overdosage may include bradycardia, hypotension, acute cardiac insufficiency and bronchospasm.</p><p>General treatment should include: close supervision, treatment in an intensive care ward, the use of gastric lavage, activated charcoal and a laxative to prevent absorption of any drug still present in the gastrointestinal tract, the use of plasma or plasma substitutes to treat hypotension and shock.</p><p>Excessive bradycardia can be countered with atropine 1&ndash;2mg intravenously and/or a cardiac pacemaker. If necessary, this may be followed by a bolus dose of glucagons 10mg intravenously. If required, this may be repeated or followed by an intravenous infusion of glucagon 1&ndash;10mg/hour depending on response. If no response to glucagons occurs or if glucagon is unavailable, a beta-adrenoceptor stimulant such as dobutamine 2.5 to 10 micrograms/Kg/minute by intravenous infusion may be given. Dobutamine, because of its positive inotropic effect could also be used to treat hypotension and acute cardiac insufficiency. It is likely that these doses would be inadequate to reverse the cardiac effects of beta-blockade if a large overdose has been taken. The dose of dobutamine should therefore be increased if necessary to achieve the required response according to the clinical condition of the patient.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Beta blocking agents, non-selective.</p><p>ATC Code: C07A A05</p><p>Propranolol is a competitive antagonist at both beta1 and beta2-adrenoceptors.</p><p>It has no agonist activity at the beta-adrenoceptor, but has membrane stabilising activity at concentrations exceeding 1&ndash;3mg/litre, though such concentrations are rarely achieved during oral therapy. Competitive beta-adrenoceptor blockade has been demonstrated in man by a parallel shift to the right in the dose-heart rate response curve to beta-agonists such as isoprenaline.</p><p>Propranolol, as with other beta-adrenoceptor blocking drugs, has negative inotropic effects, and is therefore contra-indicated in uncontrolled heart failure.</p><p>Propranolol is a racemic mixture and the active form is the S(&ndash;) isomer. With the exception of inhibition of the conversion of thyroxine to triiodothyronine it is unlikely that any additional ancillary properties possessed by R(+) propranolol, in comparison with the racemic mixture will give rise to different therapeutic effects.</p><p>Propranolol is effective and well tolerated in most ethnic populations, although the response may be less in black patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Following intravenous administration, the plasma half-life of propranolol is about 2 hours and the ratio of metabolites to parent drug in the blood is lower than after oral administration. In particular, 4-hydroxypropranolol is not present after intravenous administration.</p><p>Propranolol is completely absorbed after oral administration and peak plasma concentrations occur 1-2 hours after dosing in fasting patients. The liver removes up to 90% of an oral dose with an elimination half-life of 3 to 6 hours. Propranolol is widely and rapidly distributed throughout the body with highest levels occurring in the lungs, liver, kidney, brain and heart.</p><p>Propranolol is highly protein bound (80&ndash;95%).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Propranolol is a drug on which extensive clinical experience has been obtained.</p><p>Relevant information for the prescriber is provided elsewhere in the Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Citric acid monohydrate; Disodium edetate; Methyl Paraben; Propyl Paraben; Polyethylene glycol 400; Propylene Glycol; Saccharin sodium; Sorbitol; Strawberry flavor; Peppermint flavor; Deionized Water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months unopened
3 months opened
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C. Do not refrigerate or freeze.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bottle: White HDPE bottle.</p><p>Closure: HDPE, child resistant closure.</p><p>Pack Size: 130ml</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries (JPI)
Riyadh, Saudi Arabia
11666 Riyadh, P.O.Box 106229
Fax: +966 11 2078907

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                21 June 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>